Inactive Instrument

Rhinomed Ltd Stock price Australian S.E.

Equities

End-of-day quote Australian S.E.
- 0.00% Intraday chart for Rhinomed Ltd
Managers TitleAgeSince
Chief Executive Officer - 13-01-31
Director of Finance/CFO - 18-11-28
Members of the board TitleAgeSince
Chairman 71 15-11-30
Chief Executive Officer - 13-01-31
Director/Board Member - 22-09-07
More insiders
Rhinomed Limited is an Australia-based wearable nasal technology company. The Company is engaged in the research, development and commercialization of consumer and medical devices. The Company's products include Mute, Turbine, Pronto Sleep, Pronto Clear and Rhinoswab. Mute dilates the nasal passages making nasal breathing easier, reducing mouth breathing and helping to breathe more, snore less and sleep better. Turbine is designed to fit comfortably inside the nose and gently open each individual nostril to allow more airflow during sport, physical exertion or focused breathing, such as yoga and meditation. Rhinoswab is a patented comfortable, self-administered nasal swab that provides high-yield sampling and fits existing pathology workflows. Pronto Sleep is a vapor inhaler that gently opens the nose and delivers a soothing blend of four pure essential oils. Its nasal platform envisages multiple applications from simple stenting through to nasal drug delivery and sensor/diagnostics.
Sector
-
More about the company
  1. Stock
  2. Equities
  3. Stock RHINOMED
  4. Stock Rhinomed Ltd - Australian S.E.